Found 6 matching trials
Allogeneic SCT of NiCordĀ®, UCB-Derived Ex Vivo Expanded Stem and Progenitor Cells, in Patients With Hemoglobinopathies
PHASE1Allogeneic Stem Cell Transplantation of NiCordĀ®, Umbilical Cord Blood-Deriv...
Location
Steven & Alexandra Cohen Children's Medical Center, New York
Stem Cell Transplantation With NiCordĀ® (Omidubicel) vs Standard UCB in Patients With Leukemia, Lymphoma, and MDS
PHASE3This study is an open-label, controlled, multicenter, international, Phase ...
Long Term Follow Up Protocol for NiCord®/CordIn⢠(Omidubicel) Patients
N/AThis is an observational study that will monitor clinical outcomes of patie...
Location
UCSF Benioff Children's Hospital
Expanded Access of Omidubicel, for Allogeneic Transplantation in Patients With Hematological Malignancies
PHASE3Omidubicel is an investigational therapy for patients with high-risk hemato...
Transplantation of NiCordĀ®, Umbilical Cord Blood-derived Ex Vivo Expanded Cells, in Patients With HM
PHASE1A Study Evaluating the Safety and Efficacy of Transplantation of a single c...
Location
Cedars-Sinai Medical Center
Pilot Study Evaluating Safety & Efficacy of DCBT: NiCordĀ® & UNM CBU to Patients With Hematological Malignancies
PHASE1Pilot Study Evaluating the Safety and Efficacy of a Co-Transplantation of N...
Location
Loyola University, Cardinal Bernardin Cancer Center